Notices
Essential Drugs Division
KMSCL-e-tender for the Procurement of Specialty Drugs for the year 2026-27- Amendment published-reg
Essential Drugs Division
KMSCL-e-tender for the Procurement of Anti-Cancer Drugs for the year 2026-27- Amendment published-reg
Essential Drugs Division
KMSCL-e-tender for the Procurement of Drugs/Supplies (Category III & VIII) for the year 2026-27- Amendment published-reg
Essential Drugs Division
KMSCL-e-tender for the Procurement of Drugs (Category I & II) for the year 2026-27- Amendment published-reg
Essential Drugs Division
E-tender for the Procurement of Veterinary Medicines for the year 2025-26 – Technical Bid Evaluation – List of selected/rejected bidders/products for Price Bid evaluation– Published
Essential Drugs Division
KMSCL- Procurement of Drugs/ Supplies for the year 2026-27- Expression of Interest ( EOI) for Empanelment/ Registration of vendors- reg
Essential Drugs Division
e-Tender Document for the procurement of Biolarvicide :Bacillus Thuringienssi Israeliensis(BTI) For NVBDCP
Essential Drugs Division
KMSCL-e-tender for the procurement of Drugs (Category I & II) for the year 2026-27
Essential Drugs Division
KMSCL-e-tender for the procurement of Drugs/Supplies (category III-VIII) for the year 2026-27
Essential Drugs Division
KMSCL-e-tender for the procurement of Anti cancer Drugs for the year 2026-27
Essential Drugs Division
KMSCL - E-tender for the Procurement of Anti Haemophilia Drugs for the year 2025-26 - Technical Bid Evaluation - List of selected/rejected bidders/products for Price Bid evaluation - Published - reg
Essential Drugs Division
E-tender for the Procurement of Recombinant Growth Hormone for SATH under NPRD for the year 2025-26 – Price Bid Evaluation and Provisional bid status– Published
Essential Drugs Division
KMSCL-e-tender for the procurement of Anti cancer Drugs for the year 2026-27
Essential Drugs Division
KMSCL-e-tender for the procurement of Drugs/Supplies (category III-VIII) for the year 2026-27
Essential Drugs Division
KMSCL-e-tender for the procurement of Drugs (Category I & II) for the year 2026-27
Essential Drugs Division
E-tender for the Procurement of Veterinary Medicines for the year 2025-26 – Technical Bid Evaluation – Defects noticed/status– Published
Essential Drugs Division
e-Tender for the Procurement of Drugs & Growth Hormone for the treatment of Rare Disease for the year 2025-26 – Bidders eligible for Price Bid evaluation –Published
Essential Drugs Division
Re-tender for the Procurement of Drugs for the year 2025-26- Price Bid Evaluation- Final Bid Status - Published
Essential Drugs Division
e-Tender for the Procurement of Drugs & Growth Hormone for the treatment of Rare Disease for the year 2025-26 – Technical Bid Evaluation – status –Published
Essential Drugs Division
KMSCL –Re-tender for the Procurement of Drugs for the year 2025-26 – Price Bid Evaluation – Notice on Supplier wise rate quoted and Provisional Bid Ranking Status– Published – reg
Essential Drugs Division
KMSCL – Re-tender for the Procurement of Drugs for the year 2025-26 -Technical Bid Evaluation – List of selected/rejected bidders/products for price bid evaluation – Published – reg
Essential Drugs Division
- E-tender for the Procurement of Anti Haemophilia Drugs for the year 2025-26 – Technical Bid Evaluation – Defects noticed/status – Published
Essential Drugs Division
E-tender for the Procurement of Anti Haemophilia Drugs for the year 2025-26 – Technical Bid Evaluation – Defects noticed/status – Published" vide e-tender No. KMSCL/ED/HAEM/RC/2025/023 Dated 15.09.2025.
Essential Drugs Division
KMSCL –Re-Tender for Procurement & Supply of Drugs for Multiple Sclerosis for KSSM for the year 2025- 26–Price Bid Evaluation – Final Bid Status Published – Corrigendum
Essential Drugs Division
Re-tender for the Procurement of Drugs for the year 2025-26 – Technical Bid Evaluation – Defects noticed/status– Published--vide e-tender No. KMSCL/ED/DRUGS/RT/2025/024 Dated 25.09.2025.
Essential Drugs Division
E-tender for the Procurement of Drugs (Category I & II) for the year 2025-26 _Change in GST_Revised Final Bid Status Published - Reg
Essential Drugs Division
E-tender for the Procurement of Specialty Drugs for the year 2025-26 – Change in GST– Revised Final Bid Status Published – Reg
Essential Drugs Division
E-tender for the Procurement of Drugs/ Supplies (Category III-VIII) for the year 2025-26 – Change in GST– Revised Final Bid Status Published
Essential Drugs Division
E-tender for the Procurement of Anti-Cancer Drugs for the year 2025-26 – Change in GST– Revised Final Bid Status Published
Essential Drugs Division
LIST OF ITEMS NOT HAVING ELIGIBLE BIDDERS AGAINST THE E-TENDERS FOR THE YEAR 2025-26
Essential Drugs Division
"KMSCL- E- Tender for the Procurement of Veterinary Medicines to Animal Husbandry Department for the year 2025-26.
Essential Drugs Division
Procurement of Drugs/Supplies for the year 2026-27 - Expression of Interest (EOI) for Empanelment/Registration of Vendors - Time extension notice published -reg
Essential Drugs Division
KMSCL –Re-Tender for the procurement & supply of Salt testing Kit for NIDDCP for the year 2024-25-Price bid evaluation –Notice on Provisional bid Status Published-reg
Essential Drugs Division
KMSCL- Re-Tender for the procurement & supply of Salt testing Kit for NIDDCP for the year 2024-25- List of selected/ rejected bidder for price bid evaluation –Published-reg
Essential Drugs Division
KMSCL - E-tender for the Procurement of Drugs for the year 2025-26 – Price Bid Evaluation - Final Bid Status - Published
Essential Drugs Division
e-tender for the procurement of Anti Haemophilia Drugs for the year 2025-26 - Time Extension Notice - Published
Essential Drugs Division
E-tender for the Procurement of Drugs (Category I & II) for the year 2025-26 – Rejection of Items offered by M/s. Nandani Medical Laboratories Pvt Ltd & M/s. Healers Lab – Published
Essential Drugs Division
Technical Bid Evaluation/Sample Evaluation-Status of Bidders for Re-Tender for the procurement & supply of Salt testing Kit for NIDDCP for the year 2024-25
Essential Drugs Division
KMSCL E-tender for the Procurement of Drugs for the year 2025-26 Price Bid Evaluation - Notice on Supplier wise rate quoted and Provisional Bid Ranking Status Published reg
Essential Drugs Division
E-tender for the Procurement of Drugs for the year 2025-26 – Technical Bid Evaluation – List of selected/rejected bidders/products for Price Bid Evaluation - Published
Essential Drugs Division
KMSCL - e-TENDER FOR THE PROCUREMENT OF ANTI HAEMOPHILIA DRUGS for the year 2025-26
Essential Drugs Division
Re-tender for the procurement of Drugs/Supplies for the year 2025-26-Price Bid Evaluation- Final Bid Status-Published.Category III-VIII
Essential Drugs Division
Re-tender for the procurement of Drugs for the year 2025-26-Price Bid Evaluation- Final Bid Status-Published
Essential Drugs Division
KMSCL Re-tender for the Procurement of Drugs for the year 2025-26 Price Bid Evaluation Notice on Supplier wise rate quoted and Provisional Bid Ranking Status Published
Essential Drugs Division
Re-tender for the Procurement of Drugs/ Supplies for the year 2025-26 – Price Bid Evaluation –Notice on Supplier wise rate quoted and Provisional Bid
Essential Drugs Division
E-Tender for Procurement & Supply of Drugs for Ankylosing Spondylitis for KSSM for the year 2025-26 vide e-tender No-KMSCL/ED/ANKYLOSINGSPONDYLITIS/RC
Essential Drugs Division
KMSCL – Re-tender for the Procurement of Drugs for the year 2025-26 – Technical Bid Evaluation – List of selected/rejected bidders/products for price bid evaluation – Published – reg.
Essential Drugs Division
Re-tender for the Procurement of Specialty Drugs for the year 2025 26- Price Bid Evaluation- Final Bid Status - Published
Essential Drugs Division
Re-tender for the Procurement of Anti cancer Drugs for the year 2025-26- Price Bid Evaluation- Final Bid Status - Published
Essential Drugs Division
KMSCL – E-tender for the Procurement of Drugs for the year 2025-26Technical Bid Evaluation – Defects noticed/status - Published - reg
Essential Drugs Division
Notice on Final Bid Status of Re-Tender for Procurement & Supply of Drugs for Multiple Sclerosis for KSSM for the year 2025-26
Essential Drugs Division
KMSCL - Re-tender for the Procurement of Drugs/ Supplies for the year 2025-26 - Price Bid Evaluation - Final Bid Status - Published - reg.
Essential Drugs Division
E-tender for the Procurement of Drugs for Rare Disease the year 2025-26– Final Bid Status - Published
Essential Drugs Division
Re-tender for the procurement of Drugs/Supplies for the year 2025-26-Price Bid Evaluation-Notice on supplier wise rate quoted and provisional Bid Ranking Status -Published
Essential Drugs Division
Re-tender for the Procurement of Specialty Drugs for the year 2025-26- Price Bid Evaluation Notice on Supplier wise rate quoted and Provisional Bid Ranking Status Published
Essential Drugs Division
Re-tender for the procurement of AntiCancerDrugs for the year 2025-26-Price Bid Evaluation-Notice onsupplier wise rate quoted and provisional Bid Ranking Status -Published
Essential Drugs Division
Re-tender for the Procurement of ANTI CANCER DRUGS for the year 2025-26- Price Bid Evaluation- Final Bid Status - Published
Essential Drugs Division
KMSCL – Re-tender for the Procurement of Drugs for the year 2025-26 – Technical Bid Evaluation – Defects noticed/status –Corrigendum published– reg
Essential Drugs Division
Re -tender for the Procurement of Drugs/Supplies for the year 2025-26 –Technical Bid Evaluation – List of selected/rejected bidders/products for Price Bid Evaluation - Published
Essential Drugs Division
Re-tender for the Procurement of Anti Cancer Drugs for the year 2025 26 - Technical Bid Evaluation – List of selected/rejected bidders/products for price bid evaluation – Published
Essential Drugs Division
Re-tender for the Procurement of Specialty Drugs for the year 2025-26 - Technical Bid Evaluation – List of selected/rejected bidders/products for price bid evaluation – Published
Essential Drugs Division
e-tender for the Procurement of Drugs for the year 2025-26 – Amendment published
Essential Drugs Division
Re-tender for the Procurement of Anti-Cancer Drugs for the year 2025-26 – Price Bid Evaluation – Notice on Supplier wise rate quoted and Provisional Bid Ranking Status– Published
Essential Drugs Division
Provisional Bid Status of Price bid Evaluation of Re-Tender for Procurement & Supply of Drugs for Multiple Sclerosis for KSSM for the year 2025-26
Essential Drugs Division
E-Tender for Procurement & Supply of Drugs for Ankylosing Spondylitis for KSSM for the year 2025-26
Essential Drugs Division
KMSCL – Re-tender for the Procurement of Specialty Drugs for the year 2025-26 - Technical Bid Evaluation – Defects noticed and status– Published – reg
Essential Drugs Division
KMSCL – Re-tender for the Procurement of Anti Cancer Drugs for the year 2025-26 - Technical Bid Evaluation – Defects noticed and status– Published – reg
Essential Drugs Division
Re-tender for the Procurement of Anti Cancer Drugs year 2025-26 - Technical Bid Evaluation–List of selected/rejected bidders/products for price bid evaluation– Published
Essential Drugs Division
Procurement of Drugs/Supplies for the year 2026-27 - Invitation to suppliers meet
Essential Drugs Division
KMSCL - Re-tender for the Procurement of Specialty Drugs for the year 2025-26- Price Bid Evaluation- Final Bid Status - Published - reg
Essential Drugs Division
KMSCL - Re-tender for the Procurement of Drugs for the year 2025-26 - Bid Evaluation- Final Bid Status - Published - reg
Essential Drugs Division
List of Selected/Rejected Bidders/ Products for Price Bid Evaluation of E-Tender for Procurement & Supply of Drugs for Multiple Sclerosis for KSSM for the year 2025-26 vide re-tender No
Essential Drugs Division
List of Selected/Rejected Bidders/ Products for Price Bid Evaluation of E-Tender for Procurement & Supply of Drugs for Ankylosing Spondylitis for KSSM for the year 2025-26
Essential Drugs Division
E-tender for the Procurement of ALGLUCOSIDASE ALFA FOR INTRAVENOUS INFUSION 50mg vial for SATH under NPRD for the year 2025-26 – Price Bid Evaluation –Status– Published
Essential Drugs Division
E-tender for the Procurement of ALGLUCOSIDASE ALFA FOR INTRAVENOUS INFUSION 50mg vial for SATH under NPRD for the year 2025-26 – Technical Bid Evaluation –Status– Published
Essential Drugs Division
Re-tender for the Procurement of Drugs/Supplies for the year 2025-26- Corrigendum- Published – r
Essential Drugs Division
Re-tender for the Procurement of Drugs/Supplies for the year 2025-26 -Time Extension Notice - Published
Essential Drugs Division
KMSCL-Re-tender for the Procurement of Drugs/Supplies pre-bid meeting for the year 2025-26 - MEETING LINK
Essential Drugs Division
Re-tender for the Procurement of Specialty Drugs for the year 2025-26 vide Re-tender No. KMSCL/ED/SPL/RT/2025/020 dated 16.07.2025
Essential Drugs Division
Re-tender for the Procurement of Drugs/supplies for the year 2025-26 vide Re-tender No. KMSCL/ED/III to VIII/RT/2025/019 dated 16.07.2025
Essential Drugs Division
Re-tender for the Procurement of Drugs for the year 2025-26 –Technical Bid Evaluation -List of selected/rejected bidders/products for price bid evaluation– Published
Essential Drugs Division
Re-tender for the Procurement of Specialty Drugs for the year 2025-26 - Technical Bid Evaluation –List of selected/rejected bidders/products for price bid evaluation– Published
Essential Drugs Division
KMSCL- e-tender for the procurement of Drugs for Rare Disease for the year 2025-26
Essential Drugs Division
KMSCL- E-tender for the Procurement of Drugs/ Supplies ( category III- VIII) for the year 2025-26- Price Bid Evaluation- Final Bid Status- Published-reg
Essential Drugs Division
KMSCL- E-tender for the Procurement of Anti- Cancer Drugs for the year 2025-26- Price Bid Evaluation- Final Bid Status- Published-reg
Essential Drugs Division
KMSCL- Re-tender for the procurement of Anti- Cancer Drugs for the year 2025-26
Essential Drugs Division
KMSCL- Re-tender for the procurement of Drugs/ Supplies (category-III-VIII) for the year 2025-26
Essential Drugs Division
"KMSCL- Re-tender for the Procurement of Bleaching Power for the year 2025-26".
Essential Drugs Division
KMSCL- Re- tender for the Procurement of Drugs for the year 2025-26- Technical Bid Evaluation- Defects noticed/ status- Published- reg
Essential Drugs Division
KMSCL- Re- tender for the Procurement of Specialty Drugs for the year 2025-26- Technical Bid Evaluation- Defects noticed and status- Published
Essential Drugs Division
Notice for rejection/acceptance of item/bidder for price bid evaluation of e-tender for the procurement & supply of Salt Testing kit for NIDDCP for the year 2024-25
Essential Drugs Division
KMSCL Pre- tender zoom meeting vide e-tender for the procurement of Bleaching Powder 2025-26
Essential Drugs Division
E-tender for the Procurement of Drugs/ Supplies for the year 2025-26 - Price Bid Evaluation – Notice on Supplier wise Rate Quoted and Provisional Bid Ranking Status - Published
Essential Drugs Division
KMSCL e- tender for the procurement of Bleaching Powder for the year 2025-26
Essential Drugs Division
Re-tender for the Procurement and supply of drugs for Multiple Scieosis for KSSM for the year 2025-26
Essential Drugs Division
Procurement of Anti-Cancer Drugs for the year 2025-26 – Notice on Supplier wise rate quoted and Provisional Bid Ranking Status– Published
Essential Drugs Division
Re-Tender for the Procurement of Test kits for NVBDCP AND PLAN FUND for the year 2023-24 AND 2024-25
Essential Drugs Division
e-tender for the procurement of drugs for the year 2025-26 - Price Bid Evaluation – Notice on Supplier-wise rate quoted and Provisional Bid Ranking Status– Published
Essential Drugs Division
KMSCL – E-tender for the Procurement of Specialty Drugs for the year 2025-26 - Technical Bid Evaluation – List of selected/rejected bidders/products for price bid evaluation – Published – reg
Essential Drugs Division
KMSCL- E-tender for the Procurement of Drugs for the year 2025-26 ( category I&II) - Technical Bid Evaluation - List of selected/rejected bidders/products for Price Bid Evaluation- Published- reg
Essential Drugs Division
KMSCL-e- Tender for the procurement of Drugs for MULTIPLE SCLEROSIS FOR KSSM fro the year 2025-26
Essential Drugs Division
e-tender for the procurement of drugs for the year 2025-26 - Technical Bid Evaluation – Defects noticed/status – Published – reg"
Essential Drugs Division
Provisional Bid Status of E-tender for the Procurement of Test kits for NVBDCP & Plan fund for 2023-24 & 2024-25